16 results
P
stroke patients
I/C
intravenous thrombolysis (IVT), normal weight, non-obesity, non-overweight
O
3-mo poor functional outcome, 3-mo mortality
P
abiraterone, enzalutamide, apalutamide, docetaxel
I/C
combination therapy, hormonal treatments, chemotherapy, abiraterone vs. docetaxel, enzalutamide vs. docetaxel
O
overall survival (OS), median OS duration
P
children and young adults with HIV infection
I/C
vitamin D supplementation, placebo
O
serum 25(OH)D concentration, total BMD
P
morbidly obese patients with heart failure with reduced ejection fraction
I/C
bariatric surgery
O
ejection fraction, New York Heart Association functional class
P
Black, Asian, Mixed and Other
I/C
COVID-19 infection, White ethnic group
O
mortality, intensive care unit (ICU) admission, invasive mechanical ventilation (IMV)
P
patients with obesity
I/C
bariatric surgery, no intervention
O
reduction in CIMT, increase in FMD, and increase in NMD markers
P
Italy
I/C
COVID-19 outbreak, Regional differences in disease diffusion
O
Mortality and ICU admission rates per 100,000 inhabitants
P
condylar head fracture, mandible
I/C
open surgical treatment, closed functional treatments, open method, CFT
O
mouth opening, protrusion, laterotrusion, postoperative pain, malocclusion
P
Holstein cattle
I/C
single-trait GWAS, COJO analyses, multitrait meta-analysis
O
identified SNPs with potential pleiotropic effects, proposed candidate genes influencing the studied traits
P
emphysema
I/C
bronchoscopic lung volume reduction with endobronchial valves (EBVs), standard of care (SOC) medications
O
improvement in forced expiratory volume in first second, percentage forced expiratory volume in first second, St. George's respiratory questionnaire, and 6-minute walk distance